Leigh Baldwin & Co., LLC Amgen Inc Transaction History
Leigh Baldwin & Co., LLC
- $115 Billion
- Q4 2024
A detailed history of Leigh Baldwin & Co., LLC transactions in Amgen Inc stock. As of the latest transaction made, Leigh Baldwin & Co., LLC holds 319,228 shares of AMGN stock, worth $93.5 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
319,228Holding current value
$93.5 Million% of portfolio
0.28%Shares
1 transactions
Others Institutions Holding AMGN
# of Institutions
3,157Shares Held
417MCall Options Held
8.25MPut Options Held
6.39M-
Vanguard Group Inc Valley Forge, PA52.7MShares$15.4 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.5 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$8.62 Billion0.31% of portfolio
-
Morgan Stanley New York, NY14.6MShares$4.26 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA13.2MShares$3.87 Billion0.65% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $157B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...